308 related articles for article (PubMed ID: 22420032)
1. Analysis of exosome release and its prognostic value in human colorectal cancer.
Silva J; Garcia V; Rodriguez M; Compte M; Cisneros E; Veguillas P; Garcia JM; Dominguez G; Campos-Martin Y; Cuevas J; Peña C; Herrera M; Diaz R; Mohammed N; Bonilla F
Genes Chromosomes Cancer; 2012 Apr; 51(4):409-18. PubMed ID: 22420032
[TBL] [Abstract][Full Text] [Related]
2. A novel TP53 pathway influences the HGS-mediated exosome formation in colorectal cancer.
Sun Y; Zheng W; Guo Z; Ju Q; Zhu L; Gao J; Zhou L; Liu F; Xu Y; Zhan Q; Zhou Z; Sun W; Zhao X
Sci Rep; 2016 Jun; 6():28083. PubMed ID: 27312428
[TBL] [Abstract][Full Text] [Related]
3. TSAP6 is a novel candidate marker of poor survival in metastatic high-grade serous carcinoma.
Broner EC; Tropé CG; Reich R; Davidson B
Hum Pathol; 2017 Feb; 60():180-187. PubMed ID: 27825812
[TBL] [Abstract][Full Text] [Related]
4. Exosome-related multi-pass transmembrane protein TSAP6 is a target of rhomboid protease RHBDD1-induced proteolysis.
Wan C; Fu J; Wang Y; Miao S; Song W; Wang L
PLoS One; 2012; 7(5):e37452. PubMed ID: 22624035
[TBL] [Abstract][Full Text] [Related]
5. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer.
Liu T; Zhang X; Gao S; Jing F; Yang Y; Du L; Zheng G; Li P; Li C; Wang C
Oncotarget; 2016 Dec; 7(51):85551-85563. PubMed ID: 27888803
[TBL] [Abstract][Full Text] [Related]
6. Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice.
Lespagnol A; Duflaut D; Beekman C; Blanc L; Fiucci G; Marine JC; Vidal M; Amson R; Telerman A
Cell Death Differ; 2008 Nov; 15(11):1723-33. PubMed ID: 18617898
[TBL] [Abstract][Full Text] [Related]
7. Suppression of autophagy promotes fibroblast activation in p53-deficient colorectal cancer cells.
Inoue T; Hayashi Y; Tsujii Y; Yoshii S; Sakatani A; Kimura K; Uema R; Kato M; Saiki H; Shinzaki S; Iijima H; Takehara T
Sci Rep; 2021 Sep; 11(1):19524. PubMed ID: 34593902
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX
Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108
[TBL] [Abstract][Full Text] [Related]
9. The regulation of exosome secretion: a novel function of the p53 protein.
Yu X; Harris SL; Levine AJ
Cancer Res; 2006 May; 66(9):4795-801. PubMed ID: 16651434
[TBL] [Abstract][Full Text] [Related]
10. The Influence of Ionizing Radiation on Exosome Composition, Secretion and Intercellular Communication.
Jelonek K; Widlak P; Pietrowska M
Protein Pept Lett; 2016; 23(7):656-63. PubMed ID: 27117741
[TBL] [Abstract][Full Text] [Related]
11. GPC1 exosome and its regulatory miRNAs are specific markers for the detection and target therapy of colorectal cancer.
Li J; Chen Y; Guo X; Zhou L; Jia Z; Peng Z; Tang Y; Liu W; Zhu B; Wang L; Ren C
J Cell Mol Med; 2017 May; 21(5):838-847. PubMed ID: 28233416
[TBL] [Abstract][Full Text] [Related]
12. Plasma exosome microRNAs are indicative of breast cancer.
Hannafon BN; Trigoso YD; Calloway CL; Zhao YD; Lum DH; Welm AL; Zhao ZJ; Blick KE; Dooley WC; Ding WQ
Breast Cancer Res; 2016 Sep; 18(1):90. PubMed ID: 27608715
[TBL] [Abstract][Full Text] [Related]
13. TSAP6 facilitates the secretion of translationally controlled tumor protein/histamine-releasing factor via a nonclassical pathway.
Amzallag N; Passer BJ; Allanic D; Segura E; Théry C; Goud B; Amson R; Telerman A
J Biol Chem; 2004 Oct; 279(44):46104-12. PubMed ID: 15319436
[TBL] [Abstract][Full Text] [Related]
14. Exosomal microRNAs derived from colon cancer cells promote tumor progression by suppressing fibroblast TP53 expression.
Yoshii S; Hayashi Y; Iijima H; Inoue T; Kimura K; Sakatani A; Nagai K; Fujinaga T; Hiyama S; Kodama T; Shinzaki S; Tsujii Y; Watabe K; Takehara T
Cancer Sci; 2019 Aug; 110(8):2396-2407. PubMed ID: 31148360
[TBL] [Abstract][Full Text] [Related]
15. Tumor-derived exosomes are enriched in ΔNp73, which promotes oncogenic potential in acceptor cells and correlates with patient survival.
Soldevilla B; Rodríguez M; San Millán C; García V; Fernández-Periañez R; Gil-Calderón B; Martín P; García-Grande A; Silva J; Bonilla F; Domínguez G
Hum Mol Genet; 2014 Jan; 23(2):467-78. PubMed ID: 24067531
[TBL] [Abstract][Full Text] [Related]
16. The proto-oncogene PBF binds p53 and is associated with prognostic features in colorectal cancer.
Read ML; Seed RI; Modasia B; Kwan PP; Sharma N; Smith VE; Watkins RJ; Bansal S; Gagliano T; Stratford AL; Ismail T; Wakelam MJ; Kim DS; Ward ST; Boelaert K; Franklyn JA; Turnell AS; McCabe CJ
Mol Carcinog; 2016 Jan; 55(1):15-26. PubMed ID: 25408419
[TBL] [Abstract][Full Text] [Related]
17. The regulation of the endosomal compartment by p53 the tumor suppressor gene.
Yu X; Riley T; Levine AJ
FEBS J; 2009 Apr; 276(8):2201-12. PubMed ID: 19302216
[TBL] [Abstract][Full Text] [Related]
18. Exosomal Non Coding RNA in LIQUID Biopsies as a Promising Biomarker for Colorectal Cancer.
Baassiri A; Nassar F; Mukherji D; Shamseddine A; Nasr R; Temraz S
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32092975
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
[TBL] [Abstract][Full Text] [Related]
20. Circulating exosomal CPNE3 as a diagnostic and prognostic biomarker for colorectal cancer.
Sun B; Li Y; Zhou Y; Ng TK; Zhao C; Gan Q; Gu X; Xiang J
J Cell Physiol; 2019 Feb; 234(2):1416-1425. PubMed ID: 30078189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
